Pubblicazioni ufficiali Medesis Pharma S.A.

Azioni

Mercato chiuso - Euronext Paris Altri mercati azionari 17:35:13 14/05/2024			Variaz. 5gg	Var. 1 gen.
1,27 ^EUR	-5,58%		-4,87%	+46,31%

2023	Medesis Pharma S.A. riporta i risultati degli utili per il semestre chiuso al 30 giugno 2023	CI
2022	Medesis Pharma pubblica una nota informativa sui tre futuri farmaci in fase di sviluppo per la protezione di grandi popolazioni contaminate dopo un incidente nucleare civile o militare.	CI

Corporate officers' Statement : Sale	29/01	CO
Eligibility to PEA-PME (FR)	12/01	CO
1st-half-year results	27/10/23	CO
1st-half-year results	27/10/23	CO
Half-year report	27/10/23	CO
Corporate officers' Statement : Sale	07/07/23	CO
Shareholders meeting voting results	15/06/23	CO
Corporate officers' Statement : Sale	05/06/23	CO
General assembly meeting brochure	08/05/23	CO
Combined general shareholders meeting	08/05/23	CO
Auditors Report	04/05/23	CO
Annual Report	27/04/23	CO
Annual results	17/04/23	CO
Annual results	17/04/23	CO
Business information	04/04/23	CO
Business information	04/04/23	CO
Corporate officers' Statement : Sale	05/12/22	CO
General assembly meeting brochure	27/10/22	CO
Shareholders meeting voting results	27/10/22	CO
1st-half-year results	25/10/22	CO
Half-year report	25/10/22	CO
Changes in management and corporate officers	04/10/22	CO
Changes in management and corporate officers	04/10/22	CO
Mixed general Shareholders meeting notice	21/09/22	CO
Corporate officers' Statement : Sale	06/09/22	CO